Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -139 | -8,383 | -5,642 | -2,885 | -501 |
| Depreciation Amortization | N/A | 15 | 9 | N/A | N/A |
| Income taxes - deferred | -21 | N/A | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | N/A | 5,925 | 3,366 | 782 | N/A |
| Other Working Capital | -108 | 6,768 | 4,220 | 1,683 | 178 |
| Other Operating Activity | -220 | -5,618 | -3,161 | -680 | -68 |
| Operating Cash Flow | $-488 | $-1,293 | $-1,208 | $-1,100 | $-391 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -273 | N/A | N/A | N/A | 0 |
| Sale Of Investment | 372 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -137 | 0 | 0 | 0 |
| Investing Cash Flow | $99 | $-137 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 383 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $383 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 41 | 4,088 | 4,088 | 4,088 | 479 |
| End Cash Position | 35 | 2,659 | 2,880 | 2,988 | 88 |
| Net Cash Flow | $-6 | $-1,429 | $-1,208 | $-1,100 | $-391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -488 | -1,293 | -1,208 | -1,100 | -391 |
| Free Cash Flow | -488 | -1,293 | -1,208 | -1,100 | -391 |